Average Co-Inventor Count = 3.76
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Intellectual Property Development Limited (10 from 230 patents)
2. Astex Therapeutics Limited (8 from 123 patents)
3. Glaxosmithkline LLC (5 from 356 patents)
4. Glaxogrouplimited (1 from 8 patents)
17 patents:
1. 12091409 - Ether linked triazoles as NRF2 activators
2. 11643407 - Indanes as NRF2 activators
3. 11117905 - Bisaryl heterocycles as NRF2 activators
4. 11078216 - Bisaryl amides as NRF2 activators
5. 11059816 - Ether linked triazoles as NRF2 activators
6. 10604509 - Nrf2 regulators
7. 10485806 - Nrf2 regulators
8. 10364256 - Biaryl pyrazoles as NRF2 regulators
9. 10351530 - Arylcyclohexyl pyrazoles as NRF2 regulators
10. 10272095 - NRF2 regulators
11. 10144731 - Nrf2 regulators
12. 8501780 - Indazole carboxamides and their use
13. 8372875 - Indole carboxamides as IKK2 inhibitors
14. 8354406 - Chemical compounds
15. 8071584 - Indole carboxamides as IKK2 inhibitors